Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

Ghassan K. Abou-Alfa, Vaibhav Sahai, Antoine Hollebecque, Gina Vaccaro, Davide Melisi, Raed Al-Rajabi, Andrew S. Paulson, Mitesh J. Borad, David Gallinson, Adrian G. Murphy, Do Youn Oh, Efrat Dotan, Daniel V. Catenacci, Eric Van Cutsem, Tao Ji, Christine F. Lihou, Huiling Zhen, Luis Féliz, Arndt Vogel

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences